South San Francisco, CA – December 22nd, 2022 FDA Approves Genentech’s Actemra for the Treatment of COVID-19 in Hospitalized Adults Actemra is the first FDA-approved monoclonal antibody to treat COVID-19 Since the beginning of the pandemic, more than one million…
Tag: FDA approval
Genentech Announces Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia
South San Francisco, CA October 17, 2020 Genentech Press Release Approval supported by data from Phase III confirmatory trials, VIALE-A and VIALE-C VIALE-A study showed Venclexta plus azacitidine significantly improved overall survival in newly diagnosed AML compared to azacitidine alone…